Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China
· Delayed Price · Currency is CNY 104.31
-3.07 (-2.86%)
Mar 9, 2026, 3:00 PM CST
SHA:688016 Revenue
In the year 2025, Shanghai MicroPort Endovascular MedTech had annual revenue of 1.35B CNY with 11.96% growth. Shanghai MicroPort Endovascular MedTech had revenue of 335.85M in the quarter ending December 31, 2025, with 41.85% growth.
Revenue
1.35B
Revenue Growth
+11.96%
P/S Ratio
9.34
Revenue / Employee
1.64M
Employees
832
Market Cap
12.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.35B | 144.31M | 11.96% |
| Dec 31, 2024 | 1.21B | 19.12M | 1.61% |
| Dec 31, 2023 | 1.19B | 290.70M | 32.43% |
| Dec 31, 2022 | 896.50M | 211.87M | 30.95% |
| Dec 31, 2021 | 684.63M | 214.38M | 45.59% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cofoe Medical Technology | 3.13B |
| Shandong Weigao Orthopaedic Device | 1.54B |
| Beijing Balance Medical Technology | 630.37M |
| SonoScape Medical | 2.07B |
| Jafron Biomedical | 2.04B |
| Shanghai MicroPort EP MedTech | 464.53M |
| Beijing Wandong Medical Technology | 1.62B |
| Xiangyu Medical Co.,Ltd | 767.75M |